And so pharma profiteers again
World of DTC Marketing
APRIL 14, 2021
BMS believes they price our medicines based on the value they deliver,” but physicians say the price is too high. One of the biggest problems with a system that directs medical research towards profits rather than needs is that R&D funding is channelled to those products that can make pharma companies the most money.
Let's personalize your content